Clinical trial Recruiting at 1 site Interventional Ages 40 to 100

Using an implantable cardiac monitor to detect atrial fibrillation in stroke patients

Official title: Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.

Run by National and Kapodistrian University of Athens · NCT05494034 · Data updated 2026-11-12

This study is testing whether an implantable heart monitor can help find atrial fibrillation in stroke patients to see if it can lead to better treatment and prevent future strokes.

More Stroke trials

Quick facts

Study typeInterventional
Ages40 Years to 100 Years
SexAll
Enrollment200 (estimated)
SponsorNational and Kapodistrian University of Athens
Academic / other
Locations1 site (Athens)
StatusRecruiting
StartedMay 5, 2023
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2030
Registry record updatedNovember 9, 2023
Trial IDNCT05494034 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 40 years or older who have experienced an acute ischemic stroke or TIA and have a HAVOC score of 4 or higher.

Probably not a fit

Patients with known or newly detected atrial fibrillation at the time of hospitalization will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective cohort study aims to investigate the incidence of atrial fibrillation (AF) detected by an implantable cardiac monitoring device in patients who have experienced acute ischemic stroke. Conducted across four tertiary centers in the Athens Metropolitan area, the study will enroll consecutive patients aged 40 years or older diagnosed with acute ischemic stroke or transient ischemic attack (TIA). The research will focus on the association between detected AF, initiation of anticoagulation therapy, and the recurrence of stroke. The study will recruit approximately 200 eligible patients over a four-year period, ensuring informed consent is obtained from participants or their guardians.

Why it matters

Potential benefit: If successful, this study could lead to improved detection and management of atrial fibrillation in stroke patients, potentially reducing the risk of stroke recurrence.

How similar studies have gone: Previous studies have shown success in using implantable cardiac monitors for detecting atrial fibrillation, indicating that this approach is promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Consecutive acute ischemic stroke or TIA patients aged 40 years or older will be enrolled.
* Diagnosis of acute ischemic stroke will be based on clinical and neuroimaging evaluation \[brain computed tomography (CT) scan or magnetic resonance imaging (MRI) scan\].
* Stroke patients of all other etiologies (apart AF) presenting a HAVOC score ≥4 will be included in the study.
* Informed consent for participation in the study will be obtained from the patients or guardians of patients.

Exclusion Criteria:

* Patients with incomplete evaluation will be excluded, as previously described. \[22\] -Patients with known or newly detected AF at hospitalization will also be excluded.
* Not providing informed consent.

Where it's running

  • Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
    Athens, Greece
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.